Literature DB >> 7617447

A direct effect of forskolin on sodium channel bursting.

K Ono1, H A Fozzard, D A Hanck.   

Abstract

A long-lasting component of current through voltage-dependent Na channels is believed to contribute to the plateau phase of the cardiac action potential. Here we report that in cardiac ventricular myocytes forskolin increases the contribution of a very slow component of decay (tau = 36 +/- 16 ms, n = 13) in ensemble currents in response to step depolarizations to 0 mV. Long-lasting bursts of openings (mean duration of 27 +/- 14 ms, n = 10) accounted for this behavior. The slow time constant of decay was not altered by forskolin (5-50 microM). Rather, an increase in the probability of bursting behavior produced a forskolin concentration-dependent increase in the amplitude of this very slow component. This action of forskolin was not the result of stimulation of adenylyl cyclase because it was not affected when cAMP-dependent phosphorylation was inhibited by the protein kinase inhibitor H-89, and it could not be mimicked by addition of isoproterenol, membrane-permeant cAMP [8-(4-chlorophenylthio)-cAMP], or the phosphatase inhibitor okadaic acid. In addition, bursting was not augmented by guanosine 5'-O-(3-thiotriphosphate) (GTP [gamma S]) either applied to the bath or directly to the intracellular face of the channel in inside-out macropatches. Furthermore, 1,9-dideoxy-forskolin, which does not stimulate adenylyl cyclase and 6-(3-dimethylaminopropionyl)-forskolin, a hydrophilic derivative of forskolin, also augmented late channel activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617447     DOI: 10.1007/BF00704162

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  40 in total

1.  Dose-dependent modulation of the cardiac sodium channel by sea anemone toxin ATXII.

Authors:  N el-Sherif; H A Fozzard; D A Hanck
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

2.  Existence of two fast inactivation states in cardiac Na channels confirmed by two-stage action of proteolytic enzymes.

Authors:  Y I Zilberter; L G Motin
Journal:  Biochim Biophys Acta       Date:  1991-09-10

3.  Activators of protein kinase C inhibit sodium transport in A6 epithelia.

Authors:  M Yanase; J S Handler
Journal:  Am J Physiol       Date:  1986-03

4.  Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure.

Authors:  J Krupinski; F Coussen; H A Bakalyar; W J Tang; P G Feinstein; K Orth; C Slaughter; R R Reed; A G Gilman
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

5.  Sodium channels in cardiac Purkinje cells.

Authors:  H A Fozzard; D A Hanck; J C Makielski; B E Scanley; M F Sheets
Journal:  Experientia       Date:  1987-12-01

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine.

Authors:  A I Undrovinas; I A Fleidervish; J C Makielski
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

8.  Evidence that forskolin binds to the glucose transporter of human erythrocytes.

Authors:  V R Lavis; D P Lee; S Shenolikar
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

9.  Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery.

Authors:  J Shafiq; S Suzuki; T Itoh; H Kuriyama
Journal:  Circ Res       Date:  1992-07       Impact factor: 17.367

10.  The properties of batrachotoxin-modified cardiac Na channels, including state-dependent block by tetrodotoxin.

Authors:  L Y Huang; A Yatani; A M Brown
Journal:  J Gen Physiol       Date:  1987-09       Impact factor: 4.086

View more
  6 in total

Review 1.  A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.

Authors:  Lars S Maier
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

Review 2.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

Review 3.  Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling.

Authors:  Paul A Insel; Rennolds S Ostrom
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

4.  Ranolazine for the suppression of ventricular arrhythmia: a case series.

Authors:  Eric Yeung; Mori J Krantz; Joseph L Schuller; Rita A Dale; Mark C Haigney
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-02-17       Impact factor: 1.468

5.  Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model.

Authors:  Virginie Follin-Arbelet; Peter O Hofgaard; Harald Hauglin; Soheil Naderi; Anders Sundan; Rune Blomhoff; Bjarne Bogen; Heidi K Blomhoff
Journal:  BMC Cancer       Date:  2011-07-18       Impact factor: 4.430

6.  The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM.

Authors:  Virginie Follin-Arbelet; Kristine Misund; Elin Hallan Naderi; Hege Ugland; Anders Sundan; Heidi Kiil Blomhoff
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.